Exponent, Inc. (EXPO) EPS Estimated At $0.42

September 17, 2017 - By Peter Erickson

 Exponent, Inc. (EXPO) EPS Estimated At $0.42
Investors sentiment increased to 1.26 in 2016 Q4. Its up 0.20, from 1.06 in 2016Q3. It increased, as 10 investors sold Exponent, Inc. shares while 51 reduced holdings. 23 funds opened positions while 54 raised stakes. 23.19 million shares or 1.53% less from 23.55 million shares in 2016Q3 were reported.
Bnp Paribas Arbitrage Sa stated it has 5,681 shares or 0% of all its holdings. Tiverton Asset Limited Com has 10,346 shares. 3,391 are held by Amalgamated Bancshares. National Bank & Trust Of America Corp De invested in 186,464 shares or 0% of the stock. Credit Suisse Ag stated it has 0% in Exponent, Inc. (NASDAQ:EXPO). Tower Capital Lc (Trc) invested in 0% or 422 shares. Rhumbline Advisers holds 48,479 shares. Blackrock Fund Advisors owns 0.02% invested in Exponent, Inc. (NASDAQ:EXPO) for 2.00 million shares. Moreover, Riverbridge Prtnrs Ltd Llc has 0.69% invested in Exponent, Inc. (NASDAQ:EXPO) for 544,546 shares. Victory Cap holds 2,457 shares or 0% of its portfolio. Texas Permanent School Fund, a Texas-based fund reported 18,667 shares. Sandler holds 0.8% or 148,800 shares in its portfolio. Nordea Inv Mgmt holds 21,388 shares. California Pub Employees Retirement Sys owns 80,500 shares for 0.01% of their portfolio. Creative Planning holds 1,403 shares or 0% of its portfolio.

Wall Street await Exponent, Inc. (NASDAQ:EXPO) to release earnings on October, 18. Analysts forecast earnings per share of $0.42, exactly $0.00 or 0.00 % from 2014’s $0.42 EPS. The expected EXPO’s profit could reach $10.81M giving the stock 42.08 P/E in the case that $0.42 earnings per share is reported. After posting $0.51 EPS for the previous quarter, Exponent, Inc.’s analysts now forecast -17.65 % negative EPS growth. The stock increased 1.14% or $0.8 on September 15, reaching $70.7. About 245,729 shares traded or 157.35% up from the average. Exponent, Inc. (NASDAQ:EXPO) has risen 21.10% since September 17, 2016 and is uptrending. It has outperformed by 4.40% the S&P500.

Exponent, Inc. , along with its subsidiaries, is a science and engineering consulting company. The company has market cap of $1.82 billion. Exponent provides engineering and scientific consulting services to clients around the world. It has a 36.7 P/E ratio. The Company’s service offerings are provided on a project-by-project basis.

Another recent and important Exponent, Inc. (NASDAQ:EXPO) news was published by Nasdaq.com which published an article titled: “Exponent, Inc. (EXPO) Ex-Dividend Date Scheduled for August 30, 2017” on August 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.